Article
#ESMO20: Autolus provides glimpse of next-generation CAR-T program, showing early positive safety d
Rating:
0.0
Views:
65
Likes:
1
Library:
1
CAR-T therapies were hailed as a breakthrough when Novartis received the first FDA approval for Kymriah back in 2017. Though highly effective at treating certain types of blood cancers, CAR-Ts are also associated with severe and potentially deadly side effects, including lethal instances of cytokine release syndrome. With this in
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value